| 1 |
New use of BCG for recombinant vaccines
C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature
|
6 Jun 1991 |
1,513 |
| 2 |
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao, Jiaqi Huang, Haihong Zhong et al. · Pharmacology & Therapeutics
|
27 Sep 2013 |
674 |
| 3 |
Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
Syd Johnson, Cynthia N. Oliver, Gregory A. Prince et al. · The Journal of Infectious Diseases
Open access |
Nov 1997 |
647 |
| 4 |
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Heng Lin, Shuang Wei, Elaine M. Hurt et al. · Journal of Clinical Investigation
Open access |
15 Jan 2018 |
610 |
| 5 |
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen et al. · Cancer Discovery
Open access |
16 Jul 2018 |
481 |
| 6 |
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
Suzanne I.S. Mosely et al. · Cancer Immunology Research
|
6 Dec 2016 |
439 |
| 7 |
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000
Shelah Leader, Kimmie F. Kohlhase · The Journal of Pediatrics
|
Nov 2003 |
431 |
| 8 |
Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses
Timothy P. Welliver, Roberto P. Garofalo, Yashoda Madaiah Hosakote et al. · The Journal of Infectious Diseases
Open access |
15 Mar 2007 |
426 |
| 9 |
Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody
Ross A. Stewart et al. · Cancer Immunology Research
|
6 May 2015 |
416 |
| 10 |
The Immunoscore: Colon Cancer and Beyond
Helen K. Angell, Daniela Bruni, J. Carl Barrett et al. · Clinical Cancer Research
|
14 Aug 2019 |
411 |
| 11 |
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
Scott Koenig, Anthony J. Conley, Yambasu A. Brewah et al. · Nature Medicine
|
Apr 1995 |
382 |
| 12 |
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants
Qing Zhu, Jason S. McLellan, Nicole L. Kallewaard et al. · Science Translational Medicine
|
3 May 2017 |
374 |
| 13 |
TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma
Jérôme Biton, Audrey Mansuet‐Lupo, Nicolas Pécuchet et al. · Clinical Cancer Research
|
15 May 2018 |
372 |
| 14 |
Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF
Tomoya Matsumoto, Stefanie Rauskolb, Martin Polack et al. · Nature Neuroscience
|
20 Jan 2008 |
362 |
| 15 |
Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis
Ronan J. Walsh, Sek Won Kong, Yihong Yao et al. · Arthritis & Rheumatism
Open access |
29 Oct 2007 |
308 |
| 16 |
Targeting CD73 in the tumor microenvironment with MEDI9447
Carl M. Hay, Erin Sult, Qihui Huang et al. · OncoImmunology
Open access |
11 Jul 2016 |
292 |
| 17 |
Interleukin-6 Stimulates Defective Angiogenesis
Ganga Gopinathan, Carla S. Milagre, Oliver M.T. Pearce et al. · Cancer Research
Open access |
16 Jun 2015 |
255 |
| 18 |
Hypoxia‐induced production of stromal cell–derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts
Carol Ann Hitchon, Keng Wong, Guoping Ma et al. · Arthritis & Rheumatism
|
Oct 2002 |
253 |
| 19 |
Robust anti‐obesity and metabolic effects of a dual GLP ‐1/glucagon receptor peptide agonist in rodents and non‐human primates
Susan J Henderson et al. · Diabetes Obesity and Metabolism
Open access |
5 Jul 2016 |
239 |
| 20 |
Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.
Michael S. Kinch, Mary-Beth H Moore, David H. Harpole · PubMed
|
Feb 2003 |
239 |
| 21 |
Persistence of Morbidity and Cost Differences Between Late-Preterm and Term Infants During the First Year of Life
Kimmie K. McLaurin, Caroline Breese Hall, Elizabeth Anne Jackson et al. · PEDIATRICS
|
26 Jan 2009 |
234 |
| 22 |
Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor
Néstor A. Molfino, David L. Gossage, R. Kolbeck et al. · Clinical & Experimental Allergy
|
23 Sep 2011 |
216 |
| 23 |
A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma
Richard M. Nowak, Joseph M. Parker, Robert A. Silverman et al. · The American Journal of Emergency Medicine
|
5 Oct 2014 |
208 |
| 24 |
Self-reactive IgE exacerbates interferon responses associated with autoimmunity
Jill Hénault, Jeffrey M. Riggs, Jodi L. Karnell et al. · Nature Immunology
Open access |
21 Dec 2015 |
188 |
| 25 |
Adhesins as Targets for Vaccine Development
Theresa M. Wizemann, John E. Adamou, Solomon Langermann · Emerging infectious diseases
Open access |
Jun 1999 |
182 |
| 26 |
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W. Higgs, Wei Zhu, Chris Morehouse et al. · Annals of the Rheumatic Diseases
Open access |
24 Feb 2013 |
170 |
| 27 |
Identification of a Single Tryptophan Residue as Critical for Binding Activity in a Humanized Monoclonal Antibody against Respiratory Syncytial Virus
Ziping Wei, Jinhua Feng, Hung‐Yu Lin et al. · Analytical Chemistry
|
24 Feb 2007 |
170 |
| 28 |
Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections
William J. Rodriguez, William C. Gruber, Charles Welliver et al. · PEDIATRICS
|
Mar 1997 |
170 |
| 29 |
IL ‐33 drives airway hyper‐responsiveness through IL ‐13‐mediated mast cell: airway smooth muscle crosstalk
Davinder Kaur, E. Gomez, Camille Doe et al. · Allergy
Open access |
13 Feb 2015 |
167 |
| 30 |
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi
Solomon Langermann, Susan Palaszynski, A Sădziene et al. · Nature
Open access |
8 Dec 1994 |
167 |
| 31 |
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study
Stephen A. Harrison, Sarah Browne, John J. Suschak et al. · Journal of Hepatology
Open access |
11 Jul 2024 |
166 |
| 32 |
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev Kumar Shrimali, Shamim Ahmad, Vivek Verma et al. · Cancer Immunology Research
|
28 Aug 2017 |
160 |
| 33 |
Idiopathic Pulmonary Fibrosis in United States Automated Claims: Incidence, Prevalence, and Algorithm Validation
Daina B. Esposito, Stephan Lanes, Macarius M. Donneyong et al. · American Journal of Respiratory and Critical Care Medicine
|
4 Aug 2015 |
157 |
| 34 |
Improving target cell specificity using a novel monovalent bispecific IgG design
Yariv Mazor, Vaheh Oganesyan, Chunning Yang et al. · mAbs
Open access |
26 Jan 2015 |
154 |
| 35 |
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors
Joaquı́n Mateo et al. · Clinical Cancer Research
Open access |
23 Jun 2017 |
149 |
| 36 |
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Charu Aggarwal et al. · Clinical Cancer Research
Open access |
21 Sep 2018 |
147 |
| 37 |
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis
Wen Qi Pan et al. · Nature Communications
Open access |
12 May 2015 |
147 |
| 38 |
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody–Drug Conjugates Using Click Cycloaddition Chemistry
Michael Pete VanBrunt, Kurt D. Shanebeck, Zachary Caldwell et al. · Bioconjugate Chemistry
|
2 Sep 2015 |
144 |
| 39 |
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
Michael S. Kinch, Kelly Carles‐Kinch · Clinical & Experimental Metastasis
|
Feb 2003 |
137 |
| 40 |
Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade
Rebecca L. Pratt, Michael S. Kinch · Oncogene
|
25 Oct 2002 |
136 |
| 41 |
Synovial fibroblasts self‐direct multicellular lining architecture and synthetic function in three‐dimensional organ culture
Hans Peter Kiener, Gerald F. Watts, Yajun Cui et al. · Arthritis & Rheumatism
|
7 Jan 2010 |
135 |
| 42 |
Neuromyelitis optica spectrum disorder
Janine B. Beekman, Aysha Keisler, Omar Pedraza et al. · Neurology Neuroimmunology & Neuroinflammation
Open access |
21 Jun 2019 |
134 |
| 43 |
Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions
Wei Zheng, Harri J. Nurmi, Sila Appak‐Baskoy et al. · Genes & Development
Open access |
15 Jul 2014 |
134 |
| 44 |
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
Rodney Glenn King et al. · Vaccines
Open access |
9 Aug 2021 |
125 |
| 45 |
Role of B Cell–Activating Factor in Chronic Obstructive Pulmonary Disease
Leen Seys, Anne Verhamme, Anja Schinwald et al. · American Journal of Respiratory and Critical Care Medicine
|
12 Aug 2015 |
124 |
| 46 |
Burden of paediatric influenza in Western Europe: a systematic review
Evgeniya N. Antonova, Catherine E. Rycroft, Christopher S. Ambrose et al. · BMC Public Health
ReviewOpen access |
12 Nov 2012 |
119 |
| 47 |
Role of CXCL13 in Cigarette Smoke–induced Lymphoid Follicle Formation and Chronic Obstructive Pulmonary Disease
Ken R. Bracke, Anne Verhamme, Leen Seys et al. · American Journal of Respiratory and Critical Care Medicine
|
6 Jun 2013 |
117 |
| 48 |
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+T cell receptor repertoire clonality
Wei Zhu, Claire Germain, Zheng Liu et al. · OncoImmunology
Open access |
Jun 2015 |
116 |
| 49 |
Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action
James C. Geoghegan, Gundo Diedrich, Xiaojun Lu et al. · mAbs
Open access |
8 Feb 2016 |
114 |
| 50 |
B-cell targeted therapeutics in clinical development
Stephan Blüml, Kathleen McKeever, Rachel Ettinger et al. · Arthritis Research & Therapy
Open access |
Mar 2013 |
110 |